Ventricular Assist Devices & Artificial Hearts
This policy defines medical necessity, coverage stance, and coding for ventricular assist devices (VADs) and total artificial hearts (TAH) for Priority Health members, including LVADs, RVADs, percutaneous devices, and TAH used as bridge-to-transplant or destination therapy.
Insertion of an extracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.
Insertion of an intracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.